“When Apple launched ResearchKit more than a year ago, the promise was to allow people from all over the world to participate in studies for medical research via iPhones and other Apple devices,” Samantha Murphy Kelly reports for Mashable. “At the time, the company made clear it was not in the business of collecting medical and research data from users — that was between the subjects and the researcher (mostly hospitals and universities).”

“Now that’s changing,” Kelly reports. “Two apps have updated their fine-print details to include Apple itself as a ‘secondary’ researcher. Mole Mapper, an app from Oregon Health & Science University that tracks skin moles to help prevent melanoma, and the mPower Research App for Parkinson’s now list the tech giant as a third party that can receive medical data from study participants.”

“Apple told Mashable it wants to see how advancements its own hardware could improve studies moving forward,” Kelly reports. “‘We’ve learned a lot about the powerful role iPhone and Apple Watch can play in medical research and we know there’s even more we can do,’ an Apple spokesperson told Mashable. ‘For certain ResearchKit studies, Apple will be listed as a researcher, receiving data from participants who consent to share their data, so we can participate with the larger research community in exploring how our technology could improve the way people manage their health.'”

Read more in the full article here.

MacDailyNews Take: The very important evolution of ResearchKit continues unabated. Apple’s health efforts, including ResearchKit, HealthKit, and the new CareKit, cannot be overstated – indeed, they hold the promise of being the company’s most important contribution to the world.

SEE ALSO:
How iPhone CareKit apps will revolutionize health care – March 25, 2016
Apple advances health apps with CareKit – March 21, 2016

[Thanks to MacDailyNews Reader “Brawndo Drinker” for the heads up.]